Intelligent Bio Solutions (INBS) Debt to Equity (2020 - 2024)
Intelligent Bio Solutions has reported Debt to Equity over the past 5 years, most recently at $0.01 for Q1 2024.
- For Q1 2024, Debt to Equity fell 82.78% year-over-year to $0.01; the TTM value through Mar 2024 reached $0.01, down 82.78%, while the annual FY2023 figure was $0.11, 74.79% down from the prior year.
- Debt to Equity for Q1 2024 was $0.01 at Intelligent Bio Solutions, down from $0.07 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.43 in Q2 2022 and troughed at -$0.98 in Q2 2020.
- A 5-year average of $0.02 and a median of $0.04 in 2020 define the central range for Debt to Equity.
- Biggest five-year swings in Debt to Equity: crashed 95.87% in 2021 and later surged 48710.75% in 2022.
- Year by year, Debt to Equity stood at $0.02 in 2020, then crashed by 95.87% to $0.0 in 2021, then surged by 5107.82% to $0.05 in 2022, then soared by 48.11% to $0.07 in 2023, then crashed by 81.32% to $0.01 in 2024.
- Business Quant data shows Debt to Equity for INBS at $0.01 in Q1 2024, $0.07 in Q4 2023, and $0.25 in Q3 2023.